Skip to main content

Basic fibroblast growth factor expression in recurrent versus non-recurrent nasal polyposis

European Archives of Oto-Rhino-Laryngology and Head & Neck volume 261, pages 321–325 (2004)Cite this article

Abstract

Various growth factors are expressed in nasal polyps, and some of these have been suggested to play a role in polyp formation. A potential relation between growth factor expression and polyp recurrence, however, is undetermined. Basic fibroblast growth factor (bFGF) is expressed in mononuclear cells, as well as in endothelial and epithelial surface and gland cells of nasal polyps. To determine whether bFGF may play a role in the recurrence of nasal polyps, the present study aimed at a comparison of bFGF expression in recurrent versus non-recurrent polyps. Further, the expression in polyps from asthmatic patients was compared with that from non-asthmatics. Thirty patients with newly diagnosed nasal polyposis were included. Polypectomy was performed at entry to the long-term follow-up study. Fifteen patients only had one polypectomy (no recurrence group, with a median observation time of 81 months). Fifteen patients had a median of 6.4 polypectomies (multiple recurrence group, with a median observation time of 108 months). Five of nine patients with asthma belonged to the non-recurrence group and four to the recurrence group. The polyp from the entrance polypectomy was examined for expression of bFGF by immunohistochemistry, using a polyclonal antibody. A masked semi-quantification of staining intensity was performed in recurrent versus non-recurrent polyps, as well as in asthmatics versus non-asthmatics. bFGF expression was seen as varying staining of the polyp surface and gland epithelium, as well as of some mononuclear cells and some fibroblast-like cell profiles in the polyp stroma. Vascular endothelium was labeled occasionally. Semi-quantification of the staining intensity showed no significant differences between recurrent and non-recurrent polyps, or between asthmatics and non-asthmatics. We conclude that the level of immunohistochemical expression of bFGF in recurrent and non-recurrent nasal polyposis is equivalent. Thus, the level of bFGF expression in the primary polyp can not predict a subsequent recurrence. The expression of bFGF is not up-regulated in patients with asthma. Further studies are needed to determine a potential role of bFGF in nasal polyposis, with special reference to different stages of polyp formation and growth.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1.

References

  1. Baird A, Klagsbrun M (1991) The fibroblast growth factor family. Cancer Cells 3:239–243

    Google Scholar 

  2. Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18:26–45

    CAS  PubMed  Google Scholar 

  3. Coste A, Wang QP, Roudot-Thoraval F, chapelin C, Bedbeder P, Poron F, Peynegre R, Escudier E (1996) Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope 106:578–583

    CAS  PubMed  Google Scholar 

  4. Coste A, Wang QP, Lefaucheur JO, Lesprit E, Poron F, Peynegre R, Escudier E (1996) Transforming growth facto-beta expression in inflammatory mucosa from upper airways. Am J Respir Crit Care Med 153:636

    Google Scholar 

  5. Coste A, Brugel L, Maitre B, Boussat S, Papon JF, Wingerstmann L, Peynegre R, Escudier E (2000) Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 15:367–372

    Article  CAS  PubMed  Google Scholar 

  6. Elovic A, Wong D, Weller P, Matossian K, Galli SJ (1994) Expression of transgenic growth factor beta-1 messenger mRNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 93:864–869

    CAS  PubMed  Google Scholar 

  7. Fernig DG, Gallagher JT (1994) Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5:353–377

    CAS  PubMed  Google Scholar 

  8. Goldfarb M (1990) The fibroblast growth factor family. Cell Growth Differ 1:439–445

    CAS  PubMed  Google Scholar 

  9. Ishibashi T, Tanaka T, Nibu K, Ishimoto S, Kaga K (1998) Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 107:885–890

    CAS  PubMed  Google Scholar 

  10. Ito A, Hirota S, Mizuno H, Kawasaki Y, Takemura T, Nishiura T, Kanakura Y, Katayama Y, Nomura S, Kitamura Y (1995) Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol Int 45:715–20

    CAS  PubMed  Google Scholar 

  11. Larsen K (1996) The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 17:243–249

    CAS  PubMed  Google Scholar 

  12. Larsen K, Tos M (1997) A long-term follow-up study of nasal polyp patients after simple polypectomies. Eur Arch Otorhinolaryngol 254:85–88

    Google Scholar 

  13. Norlander T, Westermark A, van Setten G, Valtonen H, Ishizaki H, Pyykko I (2001) Basic fibroblast growth factor in nasal polyps. Immunohistochemical and quantitative findings. Rhinology 39:88–92

    CAS  PubMed  Google Scholar 

  14. Ohno I, Lea RG, Finotto S, Marshall J, Denburg J, Dolovich J, Gauldie J, Jordana M (1991) Granulocyte macrophage colony-stimulating factor gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 5:505–510

    CAS  PubMed  Google Scholar 

  15. Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, Denburg J, Harley CB, Gauldie J, Jordana M (1992) Eosinophils in chronically inflamed human upper airway tissue express transforming growth factor-beta 1 gene. J Clin Invest 89:1662–1668

    CAS  PubMed  Google Scholar 

  16. Partanen J, Vainikka S, Korhonen J, Armstrong E, Alitalo K (1992) Diverse receptors for fibroblast growth factors. Prog Growth Factor Res 4:69–83

    CAS  PubMed  Google Scholar 

  17. Petruson B, Hansson H-A, Petruson K (1988) Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps. Acta Otolaryngol (Stockh) 106:156–160

    Google Scholar 

  18. Powers MR, Qu Z, Lagesse PC, Liebler JM, Wall MA, Rosenbaum JT (1998) Expression of basic fibroblast growth factor in nasal polyps. Ann Otol Rhinol Laryngol 107:891–897

    CAS  PubMed  Google Scholar 

  19. Ristimäki A, Narko K, Enholm B, Joukov V, Alitalo K (1998) Pro-inflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413–8418

    CAS  Google Scholar 

  20. Silvestri M, Sabatini F, Scarso L, Cordone A, Dasic G, Rossi GA (2002) Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int Arch Allergy Immunol 128:51–58

    Article  CAS  PubMed  Google Scholar 

  21. Slavin J (1995) Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 19:431–444

    Article  CAS  PubMed  Google Scholar 

  22. Szebenyi G, Fallon JF (1999) Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185:45–106

    CAS  PubMed  Google Scholar 

  23. Tingsgaard PK, Bock T, Larsen PL, Tos M (1999) Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps. Acta Otolaryngol 119:362–368

    Article  CAS  PubMed  Google Scholar 

  24. Tos M (1995) Nasal polyps. Curr Opin Otolaryngol Head Neck Surg 3:31–35

    Google Scholar 

  25. Vento SL, Wolff CH, Salven PJ, Hytonen ML, Ertama LO, Malmberg CH (2000) Vascular permeability factor/vascular endothelial growth factor in nasal polyps. Acta Otolaryngol [Suppl] 543:170–174

    Google Scholar 

  26. Wang QP, Escudier E, Roudot-Thoraval F, Samad IAA, Peynegre R, Coste A (1997) Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 107:926–931

    CAS  PubMed  Google Scholar 

  27. Wittekindt C, Hess A, Bloch W, Sultanie S, Michel O (2002) Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294–298

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Otorhinolaryngology and Head and Neck Surgery, Gentofte University Hospital of Copenhagen, Copenhagen, Denmark

    Per Cayé-Thomasen, Peter Tingsgaard & Mirko Tos

  2. ENT Clinic, Jernbanegade 22, 6700, Esbjerg, Denmark

    Knud Larsen

Authors
  1. Per Cayé-Thomasen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Knud Larsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Tingsgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mirko Tos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Knud Larsen.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cayé-Thomasen, P., Larsen, K., Tingsgaard, P. et al. Basic fibroblast growth factor expression in recurrent versus non-recurrent nasal polyposis. Eur Arch Otorhinolaryngol 261, 321–325 (2004). https://doi.org/10.1007/s00405-003-0673-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-003-0673-0

Keywords

  • Immunohistochemistry
  • Polyp
  • Histopathology
  • Polypectomy
  • Asthma